Smith Group Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-120
| Closed | -$1K | – | 320 |
|
|
2021
Q4 | $1K | Hold |
120
| – | – | ﹤0.01% | 365 |
|
|
2021
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 368 |
|
|
2021
Q2 | $2K | Hold |
120
| – | – | ﹤0.01% | 358 |
|
|
2021
Q1 | $2K | Sell |
120
-3,600
| -97% | -$60K | ﹤0.01% | 324 |
|
|
2020
Q4 | $79K | Hold |
3,720
| – | – | ﹤0.01% | 209 |
|
|
2020
Q3 | $55K | Buy |
3,720
+910
| +32% | +$13.5K | ﹤0.01% | 213 |
|
|
2020
Q2 | $41K | Sell |
2,810
-30
| -1% | -$438 | ﹤0.01% | 212 |
|
|
2020
Q1 | $33K | Hold |
2,840
| – | – | ﹤0.01% | 263 |
|
|
2019
Q4 | $67K | Hold |
2,840
| – | – | ﹤0.01% | 261 |
|
|
2019
Q3 | $53K | Buy |
2,840
+530
| +23% | +$9.89K | ﹤0.01% | 275 |
|
|
2019
Q2 | $43K | Hold |
2,310
| – | – | ﹤0.01% | 282 |
|
|
2019
Q1 | $56K | Sell |
2,310
-6,600
| -74% | -$160K | ﹤0.01% | 294 |
|
|
2018
Q4 | $231K | Hold |
8,910
| – | – | 0.01% | 229 |
|
|
2018
Q3 | $282K | Buy |
+8,910
| New | +$282K | 0.01% | 226 |
|